Clinical Trial: Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06889350) titled 'Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers' on March 11.

Brief Summary: The purpose of this study is to compare the pharmacokinetics and safety of HD-P023 and coadministration of Teneligliptin and Empagliflozin in healthy adult volunteers

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: HD-P023

One tablet of HD-P023 by oral

DRUG: Teneligliptin

One tablet of Teneligliptin by oral

DRUG: Empagliflozin High

One tablet of Empagliflozin High by oral

Recruitment Status: RECRUITING

Sponsor: ...